REFERENCES
- Jalsenjak I., Nixon J. R., Senjkovic R., Stivic I. J. Pharm. Pharmacol. 1980; 32: 678
- Dechesen J. P. Int. J. Pharm. 1987; 37: 203
- Nixon J. R., Jalsenjak I., Nicolaidau C. F., Harris M. Drug Dev. Ind. Pharm. 1978; 4: 117
- Lin S. Y., Yang J. C. J. Controlled Release 1986; 3: 221
- Dubernet C., Benoit J. P., Couarraze G., Duchene D. Int. J. Pharm. 1987; 35: 145
- Chemtob C., Chaumeil J. C., N'Dongo M. Int. J. Pharm. 1986; 29: 83
- Takenaka H., Kawashima Y., Lin S. Y. J. Pharm. Sci. 1980; 69: 1388
- Lin S. Y. J. Pharm. Sci. 1988; 77: 229
- Prapaitrakul W., Whitworth C. W. Drug Dev. Ind. Pharm. 1990; 16: 1427
- Nixon J. R., Agyilirah G. A. J. Pharm. Sci. 1984; 73: 52–54
- Korsemer R. W., Gurney R., Doelker E., Buri P., Peppas N. A. Int. J. Pharm. 1983; 15: 25